INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / IBD BREAKOUT
Total 13F shares
46,443
Share change
+36,179
Total reported value
$1,535,874
Price per share
$33.08
Number of holders
11
Value change
+$1,196,672
Number of buys
2
Number of sells
2

Institutional Holders of INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) as of Q4 2023

As of 31 Dec 2023, INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,443 shares. The largest 10 holders included CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, OSAIC HOLDINGS, INC., Asset Dedication, LLC, UBS Group AG, BENJAMIN F. EDWARDS & COMPANY, INC., HOLLENCREST CAPITAL MANAGEMENT, AdvisorNet Financial, Inc, Lee Financial Co, and DHJJ Financial Advisors, Ltd.. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.